Expression of Multidrug Resistance-Related Protein (Mrp-1), Lung Resistance-Related Protein (Lrp) and Topoisomerase-Ii (Topo-Ii) in Wilms' Tumor: Immunohistochemical Study Using Tma Methodology

Abstract

Aims: MRP-1, LRP and TOPO-II are all associated with protection of the cells from the adverse eff ects of various chemotherapeutics. The aim of this study was to measure the expression of these proteins in Wilms' tumor (WT).Materials and Methods: TMA block was constructed from 14 samples of WT's and from xenografts derived from them. Sections of the TMA were used for immunostaining against MRP-1, LRP and TOPO-IIa.Results: All normal kidneys expressed MRP-1 but were either weakly or negatively stained for LRP and TOPO-IIa. In WT samples, MRP-1 was universally expressed, exclusively in the tubular component, while there was no expression of LRP and TOPO-IIa showed heterogeneous distribution. The xenografts varied in their MRP-1 and TOPO-IIa expression and exhibited weak/negative staining of LRP.Conclusions: This study shows that although all the proteins evaluated, had diff erent expression patterns in the tumor samples, the most prominent changes in expression were found for MRP-1. The exact clinical implications of these changes in expression and their relevance to the resistance of these tumors to chemotherapy requires further investigation. The fi nding of diff erent expression profi les for the multidrug resistance proteins in the original WT's and their xenografts suggests that the results of animal cancer models may be diffi cult to interpret.

The role and mechanism of WEE1 on the cisplatin resistance reversal of the HepG2/DDP human hepatic cancer cell line

“…In addition, MDR1 and MRP1 expression levels were detected with western blotting; the results demonstrated that these proteins were also significantly downregulated. These 2 proteins belong to the ABC super-family and are able to pump chemotherapeutic drugs out of the cells (12). Furthermore, the present study also demonstrated that LRP protein expression was downregulated.…”

Upregulation of Id3 inhibits cell proliferation and induces apoptosis in A549/DDP human lung cancer cells in vitro

“…Lung cancer is the most frequent cancer type worldwide and its incidence increases by 0.5% per year (15). Despite major advances in disease management, chemotherapy and radiotherapy, almost 80% of all patients with lung cancer succumb to the disease within 1 year of diagnosis and long-term survival is achieved in only 5-10% of all cases (15,16). The major obstacle in lung cancer chemotherapy is inherent and acquired drug resistance of the cancer cells (17,18), which limits the efficacy of chemotherapy.…”

Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer

“…1 In contrast to the significant reduction of mortality from heart disease, the survival rate of lung cancer patients has been at a plateau for almost three decades, with a relative 5-year survival rate of <18% in most countries. Because of the size and distribution of lung cancer, the cytoreductive surgery is not very effective for this disease and therefore chemotherapy and/or radiation are the only treatments of choice.…”

“…Despite major advances in patient management, chemotherapy and radiotherapy, nearly 80% of the patients still die within 1 year of diagnosis and long-term survival is obtained only in 5–10% of the cases. 1 …”